References
1. Guidelines for the epidemiology of infectious diseases. In2 vols. Vol. 1 / Briko N.I., Onishchenko G.G., Pokrovsky V.I. Moscow: Meditsinskoe informatsionnoe agentstvo,2019: 880 p. (in Russian)
2. Amjadi O., Rafiei A., Mardani M., Zafari P., Zarifian A. A review of the immunopathogenesis of Brucellosis. Infect Dis (Lond). 2019; 51 (5): 321-33. DOI: https://doi.org/10.1080/23744235.2019.1568545
3. Moreno E., et al. Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci USA. 2002; 99: 1-3.
4. Moreno-Lafont M.C., et al. Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients. Trans. R. Soc. Trop. Med. Hyg. 2002; 96 (3): 340-7.
5. Barquero-Calvo E., et al. Brucella abortus induces the premature death of human neutrophils through the action of its lipopolysaccharide. PLoS One. 2015; 11 (5): e1004853.
6. Byndloss M.X., et al. Brucella spp. virulence factors and immunity. Annu Rev Anim Biosci. 2016; 4: 111-27.
7. Hartigh A.B., et al. VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system. J Bacteriol. 2008; 190: 4427-36.]
8. Roset M.S., Ibañez A.E., de Souza Filho J.A., et al. Brucella cyclic β-1,2-glucan plays a critical role in the induction of splenomegaly in mice. PLoS One. 2014; 9 (7): e101279. DOI: https://doi.org/10.1371/journal.pone.0101279
9. Kaplan-Türköz B., Koelblen T., Felix C., et al. Structure of the Toll/interleukin 1 receptor (TIR) domain of the immunosuppressive Brucella effector BtpA/Btp1/TcpB. FEBS Lett. 2013; 587: 3412-6. DOI: https://doi.org/10.1016/j.febslet.2013.09.007
10. Dubrovina V.I., Konovalova Z.A., Yastremskaya K.U., Barannikova N.L., Tokareva L.E., Balakhonov S.V. The mechanisms of cellular immune response in brucellosis. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2016; 15 (6): 80-7. URL: https://doi.org/10.31631/2073-3046-2016-15-6-80-87 (in Russian)
11. Pokrovskiy V.I., Pak S.G., Briko N.I., Danilkin B.K. Infectious diseases and epidemiology: Textbook. 2nd ed. Moscow: GEOTAR-Media, 2007: 816 p. (in Russian)
12. de Figueiredo P., Ficht T.A., Rice-Ficht A., et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015; 185 (6): 1505-17. DOI: https://doi.org/10.1016/j.ajpath.2015.03.003
13. Malov V.A. Therapeutic masks for brucellosis. Farmateka [Pharmateca]. 2011; (4): 22-8. (in Russian)
14. Sauret J.M., Vilissova N. Human brucellosis. J Am Board Fam Pract. 2002; 15 (5): 401-6.
15. Kleinman C.L., et al. ChIP-seq analysis of the LuxR-type regulator VjbR reveals novel insights into the Brucella virulence gene expression network. Nucleic Acids Res. 2017; 45 (10): 5757-69.
16. Guzman-Verri C., et al. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci USA. 2008; 99: 12 375-80.
17. Döhmer P.H., et al. Identification of a type IV secretion substrate of Brucella abortus that participates in the early stages of intracellular survival. Cell Microbiol. 2014; 16 (3): 396-410.
18. Byndloss M.X., et al. How bacterial pathogens use type III and type IV secretion systems to facilitate their transmission. Curr Opin Microbiol. 2017; 35: 1-7.
19. Ke Y., Wang Y., Li W., Chen Z. Type IV secretion system of Brucella spp. and its effectors. Front Cell Infect Microbiol. 2015; 5: 72.
20. Mary C., Fouillen A., Bessette B., et al. Interaction via the N terminus of the type IV secretion system (T4SS) protein VirB6 with VirB10 is required for VirB2 and VirB5 incorporation into T-pili and for T4SS function. J Biol Chem. 2018; 293 (35) 13 415-426.
21. Kulakov Yu.K. Molecular aspects of Brucella persistence. Molekulyarnaya genetika, mikrobiologiya i virusologiya [Molecular Genetics, Microbiology, Virology]. 2016; (1): 3-8. (in Russian)
22. Gorchakova N.G. Features of the parasitic system of brucellosis. Nauchno-issledovatel'skie publikatsii [Research Publications]. 2017; (4): 14-27. (in Russian)
23. Olsen S.C., et al. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 2014; 51 (6): 1076-89.
24. Barquero-Calvo E., et al. Brucella abortus induces the premature death of human neutrophils through the action of its lipopolysaccharide. PLoS One. 2015; 11 (5) e1004853.
25. Celli J., et al. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med. 2003; 198: 545-56.
26. Myeni S., Child R., Ng T.W., et al. Brucella modulates secretory trafficking via multiple type IV secretion effector proteins. J PLoS Pathog. 2013; 9: e100356.
27. Xavier M.N., et al. Pathogenesis of Brucella spp. Open Vet Sci J. 2010; 4: 109-18.
28. Roop R.M., et al. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host. Med Microbiol Immunol. 2009; 198 (4): 221-38.
29. Herrou J., et al. Periplasmic protein EipA determines envelope stress resistance and virulence in Brucella abortus. Mol Microbiol. 2019; 111 (3): 637-61.
30. Herrou J., Willett J.W., Fiebig A., et al. Brucella periplasmic protein EipB is a molecular determinant of cell envelope integrity and virulence. J Bacteriol. 2019; 201 (12): e0013419. DOI: https://doi.org/10.1128/JB.00134-19
31. Poester F.P., Samartino L.E., Santos R.L. Pathogenesis and pathobiology of brucellosis in livestock. Rev Sci Tech. 2013; 32 (1): 105-15.
32. Altamirano-Silva P., Meza-Torres J., Castillo-Zeledón A., et al. Brucella abortus senses the intracellular environment through the BvrR/BvrS two-component system, which allows B. abortus to adapt to its replicative niche. Infect Immun. 2018; 86 (4): 713-7.
33. Forestier C., et al. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. Immunology. 2000; 165 (9): 5202-10.
34. Logvinenko O.V., Rakitina E.L., Ponomarenko D.G., Kostyuchenko M.V., Sarkisyan N.S., Berdnikiva T.V. Features of immunological parameters of blood in patients with various forms of brucellosis. Infektsiya i immunitet [Infection and Immunity]. 2013; 3 (3): 275-8. (in Russian)
35. Zheng R., et al. Meta-analysis of the changes of peripheral blood T cell subsets in patients with brucellosis. J Immunol Res. 2018; 2018: 8439813.
36. Zheleznokova G.F. Regulatory T-lymphocytes in the immune response to infection. Zhurnal infektologii [Journal of Infectology]. 2011; (1): 6-13.
37. Bahador A., et al. Frequencies of CD4+ T regulatory cells and their CD25high and FoxP3high subsets augment in peripheral blood of patients with acute and chronic brucellosis. Osong Public Health Res Perspect. 2014; 5 (3): 161-8.
38. Shevach E., et al. Control of T cell activation by CD4+CD25+ suppressor T cells. Immunol Rev. 2001; 182: 58-67.
39. De P., et al. Structural determinants in a glucose-containing lipopolysaccharide from Mycobacterium tuberculosis critical for inducing a subset of protective T cells. J Biol Chem. 2018; 293 (25): 9706-17.
40. Kilic S.S., et al. Gamma/delta T cells in patients with acute brucellosis. Clin Exp Med. 2009; 9 (2): 101-4.
41. Liautard J., et al. Identification and isolation of Brucella suis virulence genes involved in resistance to the human innate immune system. Infect Immun. 2007; 75 (11): 5167-74.
42. De Long M.F., Tsolis R.M. Brucellosis and type IV secretion. Future Microbiol. 2012; 7 (1): 47-58.
43. Dornand J., et al. Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism. Infect Immun. 2004; 72 (4): 2303-11.
44. Gao Ning, et al. Regulatory role of natural killer (NK) cells on antibody responses to Brucella abortus. Innate Immun. 2011; 17 (2): 152-63.
45. Bessoles S., et al. Human CD4+ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d-dependent but CD4-independent mechanisms. Eur J Immunol. 2009; 39 (4): 1025-35.
46. Rakitina E.L., Logvinenko O.V., Ponomarenko D.G., Kostyuchenko M.V., Borzdova I.Yu., Golub O.G. Analysis of the content of NKT-lymphocytes in patients with acute and chronic brucellosis. In: Actual problems of diseases common to humans and animals: materials of the II All-Russian Scientific-Practical Conference. 2017: 273-5. (in Russian)
47. Ponomarenko D.G., Logvinenko O.V., Sarkisian N.S., Rakitinа C.L, Golub O.G., Kulichenko A.N. A new approach to Brucellosis allergodiagnostics. Infektsiya i immunitet[Infection and Immunity]. 2013: 3 (1): 89-92. (in Russian)
48. Sarkisуan N.S., Ponomarenko D.G., Logvinenko V.O., Rakitina E.L., Kostyuchenko M.V., Kulichenko A.N. Intensity of specific sensitization and immune profile in patients with Brucellosis. Meditsinskaya immunologiya [Medical Immunology (Russia)]. 2016; 18 (4): 365-72. (in Russian). DOI:https://doi.org/10.15789/1563-0625-2016-4-365-372